Literature DB >> 7843342

Construction of plasmids useful for production of the B subunit of cholera toxin from Vibrio cholerae or a heat-labile enterotoxin from enterotoxigenic Escherichia coli.

T Tsuji1, M Kato, Y Kato, H Kawase, S Imamura, A Miyama.   

Abstract

A simple method to construct the plasmids producing the B subunit of porcine or human heatlabile enterotoxin or cholera toxin was developed, and the B subunits produced by the resulting plasmids were purified. The gene of LTp from pEWD 299 was ligated to pHSG 396 or pBluescript SK(+)-1 and the vector carrying one Xbal and EcoR1 site in the LTp-A gene was constructed. The Xbal-EcoR1 fragment of LTp-A gene was exchanged for the multicloning site of pHSG 396 containing Xbal, BamH1, Cla 1, Kpn1, Sac1 and EcoR1 sites. This plasmid (pTSU28) produced the LTp-B subunit. Moreover, the fragment of the LTp-B gene of pTSU 28 was exchanged by the EcoR1-HindIII fragment of LTh-B from E. coli H10407 strain (pTSU 35) or by the Cla 1-Hind III fragment of CT-B gene amplified by the PCR procedure with the chromosomal DNA of V. cholerae 86KT25 (pTSU 32). The DNA sequence of the CT-B subunit amplified by PCR procedure was compared and found identical to that cited in the literature [11]. After these plasmids were transformed into E. coli MV 1184 strain, the toxins produced by them were purified using a Bio-Gel A 5m affinity column for both LT-Bs and an immunobilized D-galactose affinity column for CT-B. Though both columns absorbed only the B subunit, the eluates contained a single protein corresponding to the B subunit, suggesting that each mutant produces only the B subunit.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843342     DOI: 10.1007/bf01719662

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  22 in total

1.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

2.  Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.

Authors:  K S Chen; W Strober
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

3.  Cistrons encoding Escherichia coli heat-labile toxin.

Authors:  W S Dallas; D M Gill; S Falkow
Journal:  J Bacteriol       Date:  1979-09       Impact factor: 3.490

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

6.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

7.  Direct evidence that endogenous GM1 ganglioside can mediate thymocyte proliferation.

Authors:  S Spiegel; P H Fishman; R J Weber
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

8.  Hemagglutinating activity of the B subunit(s) of the heat-labile enterotoxin isolated from chicken enterotoxigenic Escherichia coli.

Authors:  S Sugii; T Tsuji
Journal:  FEMS Microbiol Lett       Date:  1989-01-01       Impact factor: 2.742

9.  Construction of a plasmid for expression of foreign epitopes as fusion proteins with subunit B of Escherichia coli heat-labile enterotoxin.

Authors:  F Schödel; H Will
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.